CD8A and pulmonary arterial hypertension: A clinical study [36] showed that after 1 year of follow-up, PAH patients, including IPAH patients with deficiencies in NK cells and cytotoxic CD8+ T cells, were deceased, while patients with normal lymphocyte profiles were all alive.